PSI Presents: Treating Pregnant Women with Opioid or Stimulant Use Disorder

Thursday, October 14, 2021, 12:00 PM - Thursday, September 29, 2022, 1:00 PM PST, Online

Substance use, especially opioids and stimulants, continues to rise in the US, including among women of childbearing age. Pregnant women who use opioids and stimulants face many challenges to receiving appropriate care, including stigma, limited access to treatment, and fear of legal consequences. This one-hour recorded webinar is designed to assist health care providers caring for pregnant and postpartum women to understand the characteristics of evidence-based practices to treat this vulnerable population. Candy Stockton, MD, will cover the science and best practices in treating pregnant women who use opioids, stimulants, or both.

Registration
  Release Date: October 15, 2021
  Expiration Date: September 29, 2022
  Estimated Time to Complete: 1 hour
  Registration Fee: FREE

Originally recorded on 3/9/2021

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Explain two (2) ways in which MAT helps mothers with opioid use disorder and their babies.
2. Propose three (3) research-based practices to treat pregnant women with opioid or stimulant use disorder.
3. Identify three (3) barriers to care for pregnant women with opioid and/or stimulant use disorder.
4. Summarize three (3) signs of neonatal abstinence syndrome in opioid-exposed infants.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

Bibliography
Provider Resources: http://www.uclaisap.org/ca-hubandspoke/html/provider-resources.html
Factsheets and Toolkits: http://uclaisap.org/MATPrescriberSupport/html/factsheets-toolkits.html

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity.